Literature DB >> 23085575

Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients.

Gisèle Nkontchou1, Jeanne Tran Van Nhieu, Marianne Ziol, Iulia Tengher, Amel Mahmoudi, Dominique Roulot, Valérie Bourcier, Nathalie Ganne Carrie, Véronique Grando-Lemaire, Jean-Claude Trinchet, Daniel Cherqui, Michel Beaugrand.   

Abstract

BACKGROUND/AIM: Peripheral intrahepatic cholangiocarcinoma (ICC) occurring mainly in the absence of cirrhosis represents an increasing subgroup of primary liver tumors in Western countries. Histopathologic changes in the non-neoplastic liver in this context are not well characterized. PATIENTS AND METHODS: We assessed the clinical characteristics and histopathologic changes in the distant nontumoral liver of 57 consecutive White patients (34 men, mean age 59 years) referred to one medical and one surgical liver institution over a 16-year period who developed a peripheral ICC in the absence of cirrhosis or bile duct disease.
RESULTS: High alcohol consumption was observed in 11 patients (20%), 38 patients (66%) had a BMI of 25 kg/m or more, 22 patients (40%) had diabetes, two patients had hepatitis B virus infection, two others had hepatitis C virus infection, three patients had genetic hemochromatosis, and two patients had cutaneous porphyria tarda. The distant nontumoral liver was normal in 10 patients (18%). The two main histopathologic changes observed were macrovesicular steatosis (>10% of hepatocytes) in 38 patients (66%), including 11 patients (19%) with steatohepatitis, and moderate or intense hepatocyte iron overload in 22 patients (38%).
CONCLUSION: This study shows a high prevalence of macrovesicular steatosis associated or not with steatohepatitis and iron overload in patients who develop peripheral ICC in the absence of cirrhosis or bile duct disease.

Entities:  

Mesh:

Year:  2013        PMID: 23085575     DOI: 10.1097/MEG.0b013e328357cdd7

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models.

Authors:  Alexandre Doussot; Bas Groot-Koerkamp; Jimme K Wiggers; Joanne Chou; Mithat Gonen; Ronald P DeMatteo; Peter J Allen; T Peter Kingham; Michael I D'Angelica; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2015-04-24       Impact factor: 6.113

2.  Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up.

Authors:  Takayoshi Nishioka; Shoji Kubo; Shogo Tanaka; Kenichi Wakasa; Shigekazu Takemura; Masahiko Kinoshita; Genya Hamano; Yuko Kuwae; Toshihiko Shibata; Shigefumi Suehiro
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

3.  Necroptosis microenvironment directs lineage commitment in liver cancer.

Authors:  Marco Seehawer; Florian Heinzmann; Luana D'Artista; Jule Harbig; Pierre-François Roux; Lisa Hoenicke; Hien Dang; Sabrina Klotz; Lucas Robinson; Grégory Doré; Nir Rozenblum; Tae-Won Kang; Rishabh Chawla; Thorsten Buch; Mihael Vucur; Mareike Roth; Johannes Zuber; Tom Luedde; Bence Sipos; Thomas Longerich; Mathias Heikenwälder; Xin Wei Wang; Oliver Bischof; Lars Zender
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

Review 4.  Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer.

Authors:  Abigale Lade; Luke A Noon; Scott L Friedman
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.